cost Dosing Strategy for DPN: I 500 mg TID (1,500 mg/day) nitiation: Titration: May increase to 1,000 mg TID (3,000 mg/day) after 4 weeks if tolerated and response suboptimal Maintenance: 1,500-3,000 mg/day
Phillips KA, Epstein DH, Preston KL (2014) Psychostimulant addiction treatment
Folate receptor expression was reduced by 43% due to exposure to fumonisin B1
So the fair summary for BPC-157 within KLOW is: strong and interesting preclinical data, a real mechanistic rationale, and a near-total absence of the human efficacy and safety evidence that would justify confidence in the systemic claims made for it
Long-term watch items beyond the common GI events that fade within weeks include gallbladder disease (cholelithiasis 1.1% in trials), acute kidney injury (0.5%), and rare cases of pancreatitis (under 1%)
10.1006/pupt.1998.0122